ArticleClinical and translational medicine2024

Harnessing the power of structure-based design: A new lease on life for cardiovascular drug development with apelin receptor modulators.

Junxia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.